Investor profile
OCCIDENT has backed 16 European tech companies across 20 funding rounds between 2016 and 2026, joining rounds totalling €496M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: Occident Group
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Lunaphore Technologies | Switzerland | 2 | €45M |
| Lymphatica Medtech | Switzerland | 1 | €18M |
| Code Intelligence | Germany | 1 | €12M |
| resistell |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Lunaphore Technologies | Series D+ | €40M | 2023-03 |
| Lymphatica Medtech |
| Switzerland |
| 2 |
| €12M |
| Hemotune AG | Switzerland | 1 | €7.1M |
| Resistell Ag | Switzerland | 2 | €6.5M |
| Altavo | Germany | 1 | €5.0M |
| hemotune | Switzerland | 1 | €4.7M |
| core sensing | Germany | 1 | €4.5M |
| Invasight | Switzerland | 1 | €4.3M |
| ImmitraBio | Switzerland | 1 | €2.6M |
| Chipmetrics | Finland | 1 | €2.4M |
| Avelo | Switzerland | 1 | €2.3M |
| ReCatalyst | Slovenia | 1 | €1.7M |
| Cunesoft | Germany | 1 | €0 |
| Other |
| €18M |
| 2024-10 |
| Code Intelligence | Other | €12M | 2022-06 |
| resistell | Series B | €8.6M | 2022-12 |
| Hemotune AG | Series B | €7.1M | 2022-04 |
| Altavo | Series A | €5.0M | 2024-02 |
| hemotune | Series A | €4.7M | 2020-08 |
| Lunaphore Technologies | Series B | €4.7M | 2018-08 |
